A technology-driven, global health care company which discovers, develops and commercializes pharmaceutical and medical device products for markets such as ophthalmic, neurological, medical aesthetics, medical dermatological etc.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Very successful product line with not much comparable competition (Botox, Juvederm). They also developed less expensive and evasive procedures like eye lash treatments. Especially during tough eco times personal (and more affordable) luxuries like the lash and various derma treatments will allow revenue targets being met. AGN will be doing fine b/c of the current economy.